BRPI0413067A - processo para controlar a estrututra cristalina do risedronato - Google Patents

processo para controlar a estrututra cristalina do risedronato

Info

Publication number
BRPI0413067A
BRPI0413067A BRPI0413067-7A BRPI0413067A BRPI0413067A BR PI0413067 A BRPI0413067 A BR PI0413067A BR PI0413067 A BRPI0413067 A BR PI0413067A BR PI0413067 A BRPI0413067 A BR PI0413067A
Authority
BR
Brazil
Prior art keywords
risedronate
control
crystal structure
hydrate
ethylidene
Prior art date
Application number
BRPI0413067-7A
Other languages
English (en)
Inventor
Jane Ellen Godlewski
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BRPI0413067A publication Critical patent/BRPI0413067A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Glass Compositions (AREA)
  • Steroid Compounds (AREA)
  • Seasonings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Pens And Brushes (AREA)
  • Yarns And Mechanical Finishing Of Yarns Or Ropes (AREA)

Abstract

"PROCESSO PARA CONTROLAR A ESTRUTURA CRISTALINA DO RISEDRONATO". A presente invenção refere-se a um processo para controlar a forma cristalina do sal de ácido 3-piridil-1-hidróxi-etilideno-1,1-bisfosfónico (Risedronato). O processo emprega uma etapa de ajuste do pH para induzir a forma de hidrato adequada evitando, assim, a nucleação inadvertida de formas de hidrato indesejadas.
BRPI0413067-7A 2003-07-30 2004-07-15 processo para controlar a estrututra cristalina do risedronato BRPI0413067A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49122203P 2003-07-30 2003-07-30
PCT/US2004/022703 WO2005012314A1 (en) 2003-07-30 2004-07-15 Process for controlling crystal structure of risedronate

Publications (1)

Publication Number Publication Date
BRPI0413067A true BRPI0413067A (pt) 2006-10-17

Family

ID=34115482

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0413067-7A BRPI0413067A (pt) 2003-07-30 2004-07-15 processo para controlar a estrututra cristalina do risedronato

Country Status (20)

Country Link
US (1) US7002014B2 (pt)
EP (1) EP1651656B1 (pt)
JP (1) JP4423614B2 (pt)
KR (1) KR100786044B1 (pt)
CN (1) CN100439377C (pt)
AT (1) ATE493423T1 (pt)
AU (1) AU2004261561B9 (pt)
BR (1) BRPI0413067A (pt)
CA (1) CA2529470C (pt)
CO (1) CO5660304A2 (pt)
DE (1) DE602004030801D1 (pt)
IL (1) IL172676A (pt)
IS (1) IS2915B (pt)
MA (1) MA27914A1 (pt)
MX (1) MXPA06001129A (pt)
NO (1) NO335393B1 (pt)
NZ (1) NZ544030A (pt)
RU (1) RU2319706C2 (pt)
SG (1) SG144151A1 (pt)
WO (1) WO2005012314A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1775302A1 (en) 2005-10-11 2007-04-18 Sandoz A/S Method for preparing crystalline sodium risedronate
JP5052816B2 (ja) * 2006-04-26 2012-10-17 株式会社パーマケム・アジア ３−ピリジル−１−ヒドロキシエチリデン−１、１−ビスホスホン酸ナトリウム塩２．５水和物ａ型結晶の製造方法
JP5354858B2 (ja) * 2006-05-09 2013-11-27 株式会社Ａｄｅｋａ スルホンアミド化合物の金属塩を含有するポリエステル樹脂組成物
KR20090005206A (ko) 2006-05-11 2009-01-12 인드-스위프트 래버러토리즈 리미티드 순수한 리세드론산 또는 염의 제조 방법
WO2008044245A2 (en) * 2006-10-10 2008-04-17 Matrix Laboratories Ltd A process for the preparation of risedronate sodium hemipentahydrate
KR100828705B1 (ko) * 2006-12-04 2008-05-09 씨제이제일제당 (주) 리세드론산 나트륨 수화물의 제조방법
KR100775440B1 (ko) * 2006-12-20 2007-11-12 동우신테크 주식회사 리세드로네이트 나트륨 헤미펜타히드레이트의 제조방법
KR100798855B1 (ko) * 2007-02-14 2008-01-28 주식회사 엔지켐 리세드론산 나트륨 헤미펜타하이드레이트의 제조방법
KR100812528B1 (ko) * 2007-04-12 2008-03-12 보령제약 주식회사 리세드로네이트 나트륨염의 헤미펜타히드레이트의 선택적결정화방법
WO2009050731A2 (en) * 2007-06-20 2009-04-23 Alkem Laboratories Ltd Novel process for preparing risedronic acid
WO2009034580A1 (en) * 2007-09-11 2009-03-19 Fleming Laboratories Limited Improved process for the preparation of risedronate sodium hemipentahydrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
CZ282760B6 (cs) * 1991-11-22 1997-09-17 Procter And Gamble Pharmaceuticals, Inc. Risedronátové prostředky se zpožděným uvolňováním
PE20011061A1 (es) * 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato

Also Published As

Publication number Publication date
CN100439377C (zh) 2008-12-03
EP1651656A1 (en) 2006-05-03
IL172676A0 (en) 2006-04-10
IS2915B (is) 2014-12-15
EP1651656B1 (en) 2010-12-29
RU2319706C2 (ru) 2008-03-20
CA2529470C (en) 2010-11-23
CO5660304A2 (es) 2006-07-31
NO20060950L (no) 2006-02-27
WO2005012314A1 (en) 2005-02-10
ATE493423T1 (de) 2011-01-15
US7002014B2 (en) 2006-02-21
NZ544030A (en) 2008-05-30
MA27914A1 (fr) 2006-05-02
JP2007500189A (ja) 2007-01-11
KR100786044B1 (ko) 2007-12-17
DE602004030801D1 (de) 2011-02-10
AU2004261561B9 (en) 2008-10-30
KR20060054297A (ko) 2006-05-22
CN1823078A (zh) 2006-08-23
MXPA06001129A (es) 2006-04-11
IS8262A (is) 2006-01-25
AU2004261561A1 (en) 2005-02-10
SG144151A1 (en) 2008-07-29
US20050026869A1 (en) 2005-02-03
RU2006102357A (ru) 2006-07-27
NO335393B1 (no) 2014-12-08
JP4423614B2 (ja) 2010-03-03
CA2529470A1 (en) 2005-02-10
AU2004261561B2 (en) 2008-06-26
IL172676A (en) 2010-12-30

Similar Documents

Publication Publication Date Title
CO5660304A2 (es) Proceso para controlar una estructura cristalina de risedronato
AR050609A1 (es) Proceso para controlar selectivamente la cristalizacion de formas polimorficas de mesotrina
ATE491712T1 (de) Verfahren zur stabilisierung von thiophenderivaten
EA200701358A1 (ru) Кристаллические формы гидрохлорида (r)-8-хлор-1-метил-2,3,4,5-тетрагидро-1h-3-бензазепина
RS53599B1 (en) PIRIDON DERIVATIVES FOR STRESS MODULATION OF ACTIVATED PROTEIN KINASE SYSTEMS
DK1539711T3 (da) Fremgangsmåde til fremstilling af calciumsaltet af rosuvastatin
ATE478082T1 (de) Phosphonate, monophosphonamidate, bisphosphonamidate zur behandlung von virenerkrankungen
ATE497769T1 (de) Verfahren zur herstellung von ibandronat
HUP0204203A2 (en) Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
ATE435209T1 (de) Verfahren zur herstellung von montelukast-natrium
BRPI0508489A (pt) efeitos de instabilidade de controle
NO20065768L (no) Karbonsamid-opioidforbindelser
MX2007007446A (es) Procesos para la produccion de 4-aminoquinazolinas.
MXPA05013751A (es) Procedimiento e intermediarios para la preparacion de 3-(amino)-3-ciclobutilmetil-2-hidroxi-propionamida o sus sales.
EA200701852A1 (ru) Производные аминокислот
DK2229946T3 (da) Anvendelse af vækst-stimulerende protein KIAA1524
ATE372114T1 (de) Verfahren zur erhöhung des testosteronspiegels
DE602004005881D1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
DE60238056D1 (de) Verfahren zum kristallisieren von reduziertem coenzym q10 aus wässriger lösung
MY161821A (en) Composition for reducing blood lipids
ZA200800138B (en) Process for the preparation of crystalline perindopril
FI20045307A0 (fi) Kipsilevyn pinnoite ja kipsilevy
NO20062388L (no) Azitromycin multipartikkulaere doseringsformer
CY1112194T1 (el) Μεθοδοι για ρυθμιση φωτοτοξικοτητας
WO2006081543A3 (en) Crystalline phosphatase and method for use thereof

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: WARNER CHILCOTT COMPANY, LLC (PR)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25E Requested change of name of applicant rejected

Owner name: WARNER CHILCOTT COMPANY, LLC (PR)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.7 NA RPI NO 2505 DE 08/01/2019 POR TER SIDO INDEVIDA.

B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B25E Requested change of name of applicant rejected

Owner name: WARNER CHILCOTT COMPANY, LLC (PR)

Free format text: INDEFERIDO O PEDIDO DE ALTERACAO DE NOME CONTIDO NA PETICAO 870220023201 DE 17/03/2022, EM VIRTUDE DA MANUTENCAO DO INDEFERIMENTO DO PEDIDO, CONFORME PUBLICADO NA RPI2620 DE 23/03/2021.

B25B Requested transfer of rights rejected

Owner name: WARNER CHILCOTT COMPANY, LLC (PR)

Free format text: INDEFERIDO O PEDIDO DE TRANSFERENCIA CONTIDO NA PETICAO 870220023212 DE 17/03/2022, EM VIRTUDE DE TER SIDO MANTIDO O INDEFERIMENTO DO PEDIDO, CONFORME PUBLICADO NA RPI2620 DE 23/03/2021.